Paperpal Prime Logo

Cancer Gene Therapy : Impact Factor & More

eISSN: 1476-5500pISSN: 0929-1903

Key Metrics

CiteScore
8.4
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q2Cancer Research
SNIP
0.97
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cancer Gene Therapy

Cancer Gene Therapy Journal Specifications

Overview
Publisher SPRINGERNATURE
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1994
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Cancer Gene Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cancer Gene Therapy

Transcriptomic profiling of a novel gastric implantation model identifies mechanisms and pathways that drive implantation into explanted human peritoneum.
  • 23 Jun 2026
  • Cancer gene therapy
NCBP1 promotes the malignant progression of Wilms' tumor through stabilization of KPNA2 mRNA.
  • 17 Jun 2026
  • Cancer gene therapy
The Tumor-suppressive role of CNTNAP2 in glioma: Dual regulation of the NDN-ERK axis and M2 macrophage polarization.
  • 10 Jun 2026
  • Cancer gene therapy
TP53 mutation at codon 179 metabolically reprograms cancer cells to promote invasion.
  • 5 Jun 2026
  • Cancer gene therapy
The paradox of miR-107 in oncology: dual roles as a tumor suppressor and oncomiR.
  • 2 Jun 2026
  • Cancer gene therapy
GOT1 promotes endometrial cancer progression by regulating ferroptosis through the STAT3-GPX4 axis and attenuating medroxyprogesterone acetate sensitivity.
  • 2 Jun 2026
  • Cancer gene therapy
Transcriptomic profiling of a novel gastric implantation model identifies mechanisms and pathways that drive implantation into explanted human peritoneum.
  • 23 Jun 2026
  • Cancer gene therapy
NCBP1 promotes the malignant progression of Wilms' tumor through stabilization of KPNA2 mRNA.
  • 17 Jun 2026
  • Cancer gene therapy
The Tumor-suppressive role of CNTNAP2 in glioma: Dual regulation of the NDN-ERK axis and M2 macrophage polarization.
  • 10 Jun 2026
  • Cancer gene therapy
TP53 mutation at codon 179 metabolically reprograms cancer cells to promote invasion.
  • 5 Jun 2026
  • Cancer gene therapy
The paradox of miR-107 in oncology: dual roles as a tumor suppressor and oncomiR.
  • 2 Jun 2026
  • Cancer gene therapy
GOT1 promotes endometrial cancer progression by regulating ferroptosis through the STAT3-GPX4 axis and attenuating medroxyprogesterone acetate sensitivity.
  • 2 Jun 2026
  • Cancer gene therapy

FAQs on Cancer Gene Therapy